Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - risedronic acid as sodium hemipentahydrate - tablets - risedronic acid as sodium hemipentahydrate 150 mg - risedronic acid - treatment of postmenopausal osteoporosis. prevention of postmenopausal osteoporosis.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - azacitidine - lyophilized powder for suspension for sc injection / solution for infusion - azacitidine 100 mg/vial - azacitidine - azadine is indicated for treatment of patients with the following french-american- british (fab) myelodysplastic syndrome subtypes: refractory anemia (ra) or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (raeb), refractory anemia with excess blasts in transformation (raeb-t), and chronic myelomonocytic leukemia (cmmol).

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - amikacin as sulfate - solution for injection - amikacin as sulfate 250 mg / 1 ml - amikacin - amikan is indicated in the short-term treatment of gram-negative organisms, including pseudomonas and some gram-positive organisms.sensitive gram-negative organisms include; pseudomonas aeruginosa, escherichia coli., indole-positive and indole-negative proteus spp., klebsiella, enterobacter and serratia spp., minea-herralae, citrobacter freundii, salmonella, shigella, acinetobacter and providencia spp.the principal gram-positive organism sensitive to amikacin is staphylococcus aureus, including some methicillin-resistant strains. amikan has some activity against other gram-positive organisms including certain strains of streptococcus pyogenes, enterococci and diplococcus pneumoniae.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - sitagliptin as hydrochloride monohydrate - film coated tablets - sitagliptin as hydrochloride monohydrate 100 mg - sitagliptin - sitagliptin s.k. is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. important limitations of use: sitagliptin s.k. should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. sitagliptin s.k. has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using sitagliptin s.k..

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - sitagliptin as hydrochloride monohydrate - film coated tablets - sitagliptin as hydrochloride monohydrate 25 mg - sitagliptin - sitagliptin s.k. is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. important limitations of use: sitagliptin s.k. should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. sitagliptin s.k. has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using sitagliptin s.k..

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - sitagliptin as hydrochloride monohydrate - film coated tablets - sitagliptin as hydrochloride monohydrate 50 mg - sitagliptin - sitagliptin s.k. is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. important limitations of use: sitagliptin s.k. should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. sitagliptin s.k. has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using sitagliptin s.k..

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - metformin hydrochloride; vildagliptin - film coated tablets - vildagliptin 50 mg; metformin hydrochloride 1000 mg - metformin and vildagliptin - vildamed s.k. is indicated in the treatment of type 2 diabetes mellitus:- vildamed s.k. is indicated in the treatment of adult patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.- vildamed s.k. is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea.- vildamed s.k. is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in adult patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - metformin hydrochloride; vildagliptin - film coated tablets - vildagliptin 50 mg; metformin hydrochloride 850 mg - metformin and vildagliptin - vildamed s.k. is indicated in the treatment of type 2 diabetes mellitus:- vildamed s.k. is indicated in the treatment of adult patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.- vildamed s.k. is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea.- vildamed s.k. is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in adult patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - powder for solution for inj/inf - esomeprazole as sodium 40 mg/vial - esomeprazole - solezol is indicated in adult for: :• gastroesophageal reflux disease (gerd) in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate. • prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers. solezol is indicated in children and adolescents aged 1-18 years for: • gastric antisecretory treatment when the oral route is not possible, such as: gastroesophageal reflux disease (gerd) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - linezolid - solution for infusion - linezolid 2 mg / 1 ml - linezolid - therapy is indicated only when an organism resistant to all other antibiotics is suspected.linezolid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as:1) pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (mdrsp). 2) skin and soft tissue infections including diabetic foot infections. 3) enterococcal infections. combination therapy may be indicated if a concomitant gram negative pathogen is documented or suspected.